| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.4 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.13 | 0.4 |